Featured Research

from universities, journals, and other organizations

Taking Contraceptive Pill May Reduce Risk Of Developing Cancer, Study Suggests

Date:
September 12, 2007
Source:
British Medical Journal
Summary:
Taking the contraceptive pill does not increase a woman's chances of developing cancer and may even reduce the risk for most women, according to a new study. However, there was an increased risk for women who used it for more than eight years.

Since its introduction in the early 1960s, more than 300 million women are thought to have used oral contraception.
Credit: iStockphoto/Marie-france Bιlanger

Taking the contraceptive pill does not increase a woman's chances of developing cancer and may even reduce the risk for most women, according to a study published by the British Medical Journal.

However, there was an increased risk for women who used it for more than 8 years.

Since its introduction in the early 1960s, more than 300 million women are thought to have used oral contraception. Although several studies have looked at the overall balance of cancer deaths associated with oral contraceptives, none have so far examined the absolute risks or benefits.

Researchers from the University of Aberdeen analysed data spanning a 36 year period from the Royal College of General Practitioners (RCGP) Oral Contraception Study which began in 1968. The study recruited 46,000 women, with an average age of 29. Approximately half were using oral contraceptives; the other half had never taken it.

Every six months their GP provided the study with information on the women's health. In addition, three quarters of the women were 'flagged' at the NHS central registries so that deaths and cancers were notified to the study even if women had left their recruitment GP.

Professor Philip Hannaford and colleagues used the data to calculate the risk of developing any type of cancer and the main gynaecological cancers combined. They also considered the effects of variables such as age, smoking and social class.

Given the length of the study a significant number of GPs had not been able to provide updates throughout the entire study period, for example if a woman moved out of the area of their doctor. So Professor Hannaford and colleagues from the University of Aberdeen's Department of General Practice and Primary Care calculated the cancer risks using two sets of data. One that related to cancers reported while the women remained registered with their recruiting GP and whose information was more detailed (GP observation dataset) The second main study dataset which was larger, also included cancers notified by the central NHS registries after women had left their recruiting GP.

In both data sets there was no overall increased risk of cancer among pill users. When the GP observation dataset was used, women who had taken the pill at some time during their lives had a 3% reduced risk of developing any cancer. When the larger main dataset was used, the reduction was 12%. A 12% reduction equates to approximately one fewer case of cancer for every 2,200 women who have used the pill for a year and 3% equates to one fewer case of cancer for every 10,000 women.

In the main dataset women on the pill had statistically significant lower rates of large bowel/rectal, uterine body and ovarian cancer. The GP dataset also showed a reduced risk of uterine and ovarian cancer.

The researchers did sound a note of caution. When the women were examined by how long they had used the pill, women who used it for more than 8 years -- less than a quarter of pill users in the study - had a statistically significant increased risk of developing any cancer, in particular cervical and central nervous system cancer. However the same women were at reduced risk of developing ovarian cancer. Evidence suggests that the protective effect of taking the pill lasts for at least 15 years after stopping.

The authors say that many women, especially those who used the first generation of oral contraceptives many years ago, are likely to find the results reassuring:

"In this UK cohort oral contraception was not associated with an overall increased risk of any cancer, indeed it may even produce a net public health gain.


Story Source:

The above story is based on materials provided by British Medical Journal. Note: Materials may be edited for content and length.


Cite This Page:

British Medical Journal. "Taking Contraceptive Pill May Reduce Risk Of Developing Cancer, Study Suggests." ScienceDaily. ScienceDaily, 12 September 2007. <www.sciencedaily.com/releases/2007/09/070911202503.htm>.
British Medical Journal. (2007, September 12). Taking Contraceptive Pill May Reduce Risk Of Developing Cancer, Study Suggests. ScienceDaily. Retrieved July 30, 2014 from www.sciencedaily.com/releases/2007/09/070911202503.htm
British Medical Journal. "Taking Contraceptive Pill May Reduce Risk Of Developing Cancer, Study Suggests." ScienceDaily. www.sciencedaily.com/releases/2007/09/070911202503.htm (accessed July 30, 2014).

Share This




More Health & Medicine News

Wednesday, July 30, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Health Insurers' Profits Slide

Health Insurers' Profits Slide

Reuters - Business Video Online (July 30, 2014) — Obamacare-related costs were said to be behind the profit plunge at Wellpoint and Humana, but Wellpoint sees the new exchanges boosting its earnings for the full year. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com
Concern Grows Over Worsening Ebola Crisis

Concern Grows Over Worsening Ebola Crisis

AFP (July 30, 2014) — Pan-African airline ASKY has suspended all flights to and from the capitals of Liberia and Sierra Leone amid the worsening Ebola health crisis, which has so far caused 672 deaths in Guinea, Liberia and Sierra Leone. Duration: 00:43 Video provided by AFP
Powered by NewsLook.com
At Least 20 Chikungunya Cases in New Jersey

At Least 20 Chikungunya Cases in New Jersey

AP (July 30, 2014) — At least 20 New Jersey residents have tested positive for chikungunya, a mosquito-borne virus that has spread through the Caribbean. (July 30) Video provided by AP
Powered by NewsLook.com
Generics Eat Into Pfizer's Sales

Generics Eat Into Pfizer's Sales

Reuters - Business Video Online (July 29, 2014) — Pfizer, the world's largest drug maker, cut full-year revenue forecasts because generics could cut into sales of its anti-arthritis drug, Celebrex. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins